LFVN Lifevantage Corp

Price (delayed)

$6.18

Market cap

$77.42M

P/E Ratio

15.45

Dividend/share

$0.19

EPS

$0.4

Enterprise value

$72.37M

?
Relative Growth: Rel. Growth: 20
Relative Strength: Rel. Strength: 40
Relative Valuation: Rel. Valuation: 81
Relative Profitability: Rel. Profitability: 62

LifeVantage Corporation, the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work ...

Highlights
LFVN's quick ratio is up by 20% since the previous quarter and by 3.5% year-on-year
The debt has contracted by 15% YoY and by 3.3% from the previous quarter
The price to earnings (P/E) is 32% more than the last 4 quarters average of 11.7 but 29% less than the 5-year quarterly average of 21.7
LFVN's EPS has shrunk by 50% YoY and by 13% QoQ
The net income has contracted by 48% YoY and by 12% from the previous quarter

Key stats

What are the main financial stats of LFVN

LFVN stock price

How has the Lifevantage stock price performed over time
Intraday
0%
1 week
-5.07%
1 month
-5.94%
1 year
-42.3%
YTD
0.32%
QTD
-0.96%

Financial performance

How have Lifevantage's revenue and profit performed over time
Revenue
$182.59M
Gross profit
$141.61M
Operating income
$6.1M
Net income
$5.07M
Gross margin
77.6%
Net margin
2.8%
LFVN's operating income is down by 50% year-on-year and by 7% since the previous quarter
The net income has contracted by 48% YoY and by 12% from the previous quarter
The company's operating margin fell by 38% YoY and by 2.9% QoQ
The net margin has contracted by 35% YoY and by 3.4% from the previous quarter

Price vs fundamentals

How does LFVN's price correlate with its fundamentals

Growth

What is Lifevantage's growth rate over time

Valuation

What is Lifevantage stock price valuation
P/E
15.45
P/B
2.32
P/S
0.42
EV/EBIT
11.93
EV/EBITDA
7.08
EV/Sales
0.4
LFVN's EPS has shrunk by 50% YoY and by 13% QoQ
The price to earnings (P/E) is 32% more than the last 4 quarters average of 11.7 but 29% less than the 5-year quarterly average of 21.7
The price to book (P/B) is 23% lower than the 5-year quarterly average of 3.0 and 7% lower than the last 4 quarters average of 2.5
The company's equity fell by 3% YoY
The revenue has declined by 20% year-on-year and by 7% since the previous quarter
The P/S is 5% more than the 5-year quarterly average of 0.4 and 5% more than the last 4 quarters average of 0.4

Efficiency

How efficient is Lifevantage business performance
The return on invested capital has dropped by 53% year-on-year and by 9% since the previous quarter
LFVN's return on equity has dropped by 51% year-on-year and by 12% since the previous quarter
The company's return on assets fell by 41% YoY and by 9% QoQ
LFVN's ROS is down by 39% YoY and by 6% QoQ

Dividends

What is LFVN's dividend history
DPS
$0.19
Dividend yield
3.07%
Payout ratio
47.5%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Lifevantage financials performed over time
Lifevantage's total assets is 118% more than its total liabilities
The company's total liabilities fell by 24% YoY
LFVN's quick ratio is up by 20% since the previous quarter and by 3.5% year-on-year
The debt is 71% less than the equity
The debt has contracted by 15% YoY and by 3.3% from the previous quarter
The company's debt to equity fell by 15% YoY and by 6% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.